In situ visualization of opioid and cannabinoid drug effects using phosphosite-specific gpcr antibodies

HIGHLIGHTS

• who: Sebastian Fritzwanker from the Universitu00e4t Jena, Drackendorfer Strau00dfe, Jena, Germany have published the Article: In situ visualization of opioid and cannabinoid drug effects using phosphosite-specific GPCR antibodies, in the Journal: (JOURNAL) of 30/03/2023
• what: The authors provide a proof of concept for using phosphorylation state-specific antibodies as sensors to elucidate GPCR activation in native tissues.
• how: For the direct stainings the authors used CyTM3 (706-165-148 anti-guinea pig) and CyTM3 (705-165-147 anti-goat) both obtained from Jackson ImmunoResearch. Source data are provided with this . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.